Risk of ischemic complications related to the intensity of triptan and ergontamine use

E.A. van der Wammes-van der Heijden, H. Rahimtoola, H.G.M. Leufkens, C.C. Tijssen, A.C.G. Egberts

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1128-1134
Number of pages7
JournalNeurology
Volume67
Publication statusPublished - 2006

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this